![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
X
20
Leo Pharma A/s Ballerup Dk, based in Denmark, is a pharmaceutical company.
One of their significant offerings is Sodium fusidate, Sterile, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R0-CEP 2009-380 - Rev 00
This Chemical Type CEP, issued on November 14, 2011, remains in force until May 26, 2016, ensuring its reliability within the pharmaceutical industry.
Substance Number 848 associated with this CEP further emphasizes